Old names:
Owner | Filings | Transaction Date | Type of Owner |
---|---|---|---|
Moore Paul Andrew | 0001938192 | Jul-18-2022 | officer: Chief Scientific Officer |
Astle Christopher | 0001915257 | Feb-24-2022 | officer: SVP & Chief Financial Officer |
Galbraith Kenneth | 0001567045 | Jan-15-2022 | director, officer: Chair, President & CEO |
Josephson Neil | 0001864141 | May-16-2021 | officer: Interim Chief Medical Officer |
Neu Kelvin | 0001554699 | May-06-2021 | director |
Priour James | 0001843630 | Jan-25-2021 | officer: Chief Commercial Officer |
BAKER JULIAN | 0001087939 | Mar-16-2020 | director |
BAKER FELIX | 0001087940 | Mar-16-2020 | director |
BAKER BROS. ADVISORS LP | 0001263508 | Mar-16-2020 | director |
Baker Brothers Life Sciences LP | 0001363364 | Mar-16-2020 | director |
667, L.P. | 0001551139 | Mar-16-2020 | director |
Baker Bros. Advisors (GP) LLC | 0001580575 | Mar-16-2020 | director |
O'Driscoll Kathryn | 0001791978 | Oct-14-2019 | officer: Chief People Officer |
Mahony Susan | 0001463321 | Jun-03-2019 | director |
Cox Troy | 0001696923 | Jun-03-2019 | director |
RENTON HOLLINGS | 0001187333 | Jan-01-2019 | director |
Zoth Lota S. | 0001278219 | Jan-01-2019 | director |
HAUSMAN DIANA | 0001563992 | Jan-01-2019 | officer: Chief Medical Officer |
Hillan Kenneth J. | 0001600359 | Jan-01-2019 | director |
Sacks Natalie | 0001683811 | Jan-01-2019 | director |
Polverino Anthony J. | 0001729957 | Jan-01-2019 | officer: Chief Scientific Officer |
Tehrani Ali | 0001761853 | Jan-01-2019 | director, officer: Chief Executive Officer |
Bedford Nick | 0001761855 | Jan-01-2019 | director |
Klompas Neil A | 0001761857 | Jan-01-2019 | officer: Chief Financial Officer |
Poon David Kai Yuen | 0001761966 | Jan-01-2019 | officer: See Remarks |
LILLY ELI & CO | 0000059478 | May-03-2017 | 10 percent owner |
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Zymeworks Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000070858-23-000084 (34 Act) Size: 87 KB |
Feb-14-2023 | 23623454 |
SC 13G/A | Document | Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000846087-23-000035 (34 Act) Size: 32 KB |
Feb-06-2023 | 23589953 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000899243-22-035785 ( Act) Size: 10 KB |
Nov-14-2022 | |
15-12G | Document | Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001193125-22-267073 (34 Act) Size: 13 KB |
Oct-24-2022 | 221324776 |
8-K | Document | Current report filing Acc-no: 0001193125-22-266764 (34 Act) Size: 470 KB |
Oct-21-2022 | 221323978 |
8-K | Document | Current report filing Acc-no: 0001193125-22-264879 (34 Act) Size: 294 KB |
Oct-19-2022 | 221317215 |
8-K | Document | Current report filing Acc-no: 0001193125-22-264102 (34 Act) Size: 255 KB |
Oct-18-2022 | 221314874 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-22-262216 (33 Act) Size: 91 KB |
Oct-13-2022 | 221309442 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-22-262212 (33 Act) Size: 83 KB |
Oct-13-2022 | 221309431 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-22-262206 (33 Act) Size: 82 KB |
Oct-13-2022 | 221309416 |
S-8 POS | Document | Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-22-262204 (33 Act) Size: 89 KB |
Oct-13-2022 | 221309409 |
POSASR | Document | Post-effective Amendment to an automatic shelf registration statement on Form S-3ASR or Form F-3ASR Acc-no: 0001193125-22-262189 (33 Act) Size: 120 KB |
Oct-13-2022 | 221309376 |
25-NSE | Document | Acc-no: 0000876661-22-000832 (34 Act) Size: 3 KB | Oct-13-2022 | 221308909 |
25-NSE | Document | Acc-no: 0000876661-22-000831 (34 Act) Size: 4 KB | Oct-13-2022 | 221308902 |
425 | Document | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0001193125-22-261347 (34 Act) Size: 35 KB |
Oct-12-2022 | 221307188 |
8-K | Document | Current report filing Acc-no: 0001193125-22-261341 (34 Act) Size: 208 KB |
Oct-12-2022 | 221307176 |
425 | Document | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0001193125-22-259760 (34 Act) Size: 181 KB |
Oct-11-2022 | 221301820 |
8-K | Document | Current report filing Acc-no: 0001193125-22-259757 (34 Act) Size: 332 KB |
Oct-11-2022 | 221301816 |
425 | Document | Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0001193125-22-257272 (34 Act) Size: 64 KB |
Oct-04-2022 | 221289815 |
8-K | Document | Current report filing Acc-no: 0001193125-22-257268 (34 Act) Size: 201 KB |
Oct-04-2022 | 221289808 |
Recent 20 filings. View all Zymeworks Inc. filings
young lad who new his job ansered questions and new what was best for me.
It's being easier working on the website. And I recommend, it's a great website
Huge help thank you for your help .. y'all make it so much easier
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by